微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.61% | -29.07% | -75% | 50/71 | 2.21% | ST目药 | 9.27% | 行业排名> |
| 2024-12-31 | 2.44% | -37.6% | -5.43% | 42/71 | 3.08% | ST目药 | 22.26% | 行业排名> |
| 2024-09-30 | 2.58% | -28.13% | 54.49% | 45/71 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 1.67% | -26.11% | 94.19% | 43/71 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.86% | 11.69% | -78.01% | 51/71 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 3.91% | 16.37% | 8.91% | 45/71 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 3.59% | -0.28% | 58.85% | 48/71 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 2.26% | 20.86% | 193.51% | 51/71 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 0.77% | -30% | -77.08% | 58/71 | 2.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 3.36% | -33.2% | -6.67% | 46/71 | 7.39% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 3.6% | -5.51% | 92.51% | 45/71 | 5.07% | 片仔癀 | 19.69% | 行业排名> |
| 2022-06-30 | 1.87% | -35.52% | 70% | 51/71 | 3.13% | 片仔癀 | 12.75% | 行业排名> |
| 2022-03-31 | 1.1% | -24.66% | -78.13% | 51/71 | 2.15% | 片仔癀 | 6.88% | 行业排名> |
| 2021-12-31 | 5.03% | 23.28% | 32.02% | 46/71 | 4.45% | 片仔癀 | 27.39% | 行业排名> |
| 2021-09-30 | 3.81% | 49.41% | 31.38% | 53/71 | 7.44% | 片仔癀 | 23.14% | 行业排名> |
| 2021-06-30 | 2.9% | 286.67% | 98.63% | 53/71 | 4.61% | 片仔癀 | 13.23% | 行业排名> |
| 2021-03-31 | 1.46% | 640.74% | -64.22% | 49/71 | -2.87% | *ST长药 | 7.37% | 行业排名> |
| 2020-12-31 | 4.08% | -13.92% | 60% | 46/71 | -2.08% | 沃华医药 | 22.84% | 行业排名> |
| 2020-09-30 | 2.55% | -35.44% | 240% | 58/71 | 5.56% | 沃华医药 | 19.47% | 行业排名> |
| 2020-06-30 | 0.75% | -67.67% | 377.78% | 57/71 | 3.25% | 沃华医药 | 12.7% | 行业排名> |
| 2020-03-31 | -0.27% | -121.77% | -105.7% | 61/71 | 1.91% | 济川药业 | 7.33% | 行业排名> |
| 2019-12-31 | 4.74% | 121.02% | 20% | 45/71 | 3.89% | 济川药业 | 27.43% | 行业排名> |
| 2019-09-30 | 3.95% | -3.19% | 70.26% | 46/71 | 7.09% | 济川药业 | 23.05% | 行业排名> |
| 2019-06-30 | 2.32% | -15.94% | 87.1% | 50/71 | 4.58% | 济川药业 | 15.79% | 行业排名> |
| 2019-03-31 | 1.24% | 8.77% | 105.5% | 51/71 | 2.86% | 华润三九 | 10.23% | 行业排名> |
| 2018-12-31 | -22.55% | -590.22% | -652.7% | 68/71 | 7.68% | 济川药业 | 32.79% | 行业排名> |
| 2018-09-30 | 4.08% | 6.81% | 47.83% | 50/71 | 7.89% | 济川药业 | 27.55% | 行业排名> |
| 2018-06-30 | 2.76% | 27.19% | 142.11% | 48/71 | 4.92% | 济川药业 | 17.62% | 行业排名> |
| 2018-03-31 | 1.14% | 39.02% | -75.22% | 48/71 | 2.71% | 济川药业 | 10.07% | 行业排名> |
| 2017-12-31 | 4.6% | 43.3% | 20.42% | 55/71 | 9.76% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-09-30 | 3.82% | 7.91% | 76.04% | 55/71 | 8.29% | 济川药业 | 24.2% | 行业排名> |
| 2017-06-30 | 2.17% | -0.46% | 164.63% | 57/71 | 5.16% | *ST大药 | 15.31% | 行业排名> |
| 2017-03-31 | 0.82% | -18% | -74.45% | 52/71 | 2.6% | 济川药业 | 14.64% | 行业排名> |
| 2016-12-31 | 3.21% | -49.77% | -9.32% | 59/71 | 9.95% | 济川药业 | 7.64% | 行业排名> |
| 2016-09-30 | 3.54% | -33.83% | 62.39% | 50/71 | 9.31% | 维康药业 | 38.23% | 行业排名> |
| 2016-06-30 | 2.18% | -33.94% | 118% | 53/71 | 5.02% | 太极集团 | 58.41% | 行业排名> |
| 2016-03-31 | 1% | -27.01% | -84.35% | 48/71 | 4.04% | 新光药业 | 16.54% | 行业排名> |
| 2015-12-31 | 6.39% | -5.75% | 19.44% | 49/71 | 11.27% | 太极集团 | 71.6% | 行业排名> |
| 2015-09-30 | 5.35% | 11.69% | 62.12% | 43/71 | 8.43% | 维康药业 | 48.67% | 行业排名> |
| 2015-06-30 | 3.3% | 33.06% | 140.88% | 45/71 | 5.48% | 济川药业 | 21.37% | 行业排名> |
| 2015-03-31 | 1.37% | 132.2% | -79.79% | 44/71 | 2.93% | 贵州三力 | 15.84% | 行业排名> |